Search by Drug Name or NDC
NDC 73152-0028-16 Pryidostigmine Bromide 60 mg/5mL Details
Pryidostigmine Bromide 60 mg/5mL
Pryidostigmine Bromide is a ORAL SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Athem LLC. The primary component is PYRIDOSTIGMINE BROMIDE.
MedlinePlus Drug Summary
Pyridostigmine is used to decrease muscle weakness resulting from myasthenia gravis.
Related Packages: 73152-0028-16Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Pyridostigmine
Product Information
| NDC | 73152-0028 |
|---|---|
| Product ID | 73152-028_f795dd02-2910-d691-e053-6294a90a88e0 |
| Associated GPIs | |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | Pryidostigmine Bromide |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Pyridostigmine Bromide |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | SOLUTION |
| Route | ORAL |
| Active Ingredient Strength | 60 |
| Active Ingredient Units | mg/5mL |
| Substance Name | PYRIDOSTIGMINE BROMIDE |
| Labeler Name | Athem LLC |
| Pharmaceutical Class | Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA208797 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 73152-0028-16 (73152002816)
| NDC Package Code | 73152-028-16 |
|---|---|
| Billing NDC | 73152002816 |
| Package | 473 mL in 1 BOTTLE, PLASTIC (73152-028-16) |
| Marketing Start Date | 2021-02-25 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |